HDAC INHIBITOR IN COMBINATION WITH VEGF/VEGFR INTERACTION FOR CANCER THERAPY BASED ON PLATELET COUNT

• 收藏
• 分享

专利权人:

4SC AG

发明人:

Rolf KRAUSS,Takuya KIMURA,Masatoshi KUDO

申请号：

US15766197

公开号：

US20200016118A1

申请日:

2017.04.05

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The invention relates to methods, composition and uses for the of treatment of cancer selected from the group consisting of HCC, RCC, NSCLC, ovarian cancer, CCA, PTC and FTC in a subject, which comprise administering an HDAC inhibitor in combination with a compound inhibiting the VEGF/VEGFR interaction, wherein said subject is characterized in having a platelet count of about 140000 platelets/μl or higher.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/